Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PROCTER & GAMBLE HEALTH vs PLETHICO PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PROCTER & GAMBLE HEALTH PLETHICO PHARMA PROCTER & GAMBLE HEALTH/
PLETHICO PHARMA
 
P/E (TTM) x 34.5 -0.1 - View Chart
P/BV x 10.5 0.0 62,731.2% View Chart
Dividend Yield % 2.0 0.0 -  

Financials

 PROCTER & GAMBLE HEALTH   PLETHICO PHARMA
EQUITY SHARE DATA
    PROCTER & GAMBLE HEALTH
Jun-23
PLETHICO PHARMA
Mar-14
PROCTER & GAMBLE HEALTH/
PLETHICO PHARMA
5-Yr Chart
Click to enlarge
High Rs5,366254 2,112.4%   
Low Rs3,88331 12,425.6%   
Sales per share (Unadj.) Rs740.7604.6 122.5%  
Earnings per share (Unadj.) Rs138.232.5 425.5%  
Cash flow per share (Unadj.) Rs155.251.3 302.2%  
Dividends per share (Unadj.) Rs95.000-  
Avg Dividend yield %2.10-  
Book value per share (Unadj.) Rs447.6473.7 94.5%  
Shares outstanding (eoy) m16.6034.07 48.7%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x6.20.2 2,646.5%   
Avg P/E ratio x33.54.4 762.0%  
P/CF ratio (eoy) x29.82.8 1,072.9%  
Price / Book Value ratio x10.30.3 3,431.3%  
Dividend payout %68.70-   
Avg Mkt Cap Rs m76,7614,859 1,579.8%   
No. of employees `000NANA-   
Total wages/salary Rs m2,0621,547 133.3%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m12,29620,598 59.7%  
Other income Rs m184419 43.8%   
Total revenues Rs m12,48021,017 59.4%   
Gross profit Rs m3,2472,938 110.5%  
Depreciation Rs m281642 43.8%   
Interest Rs m81,747 0.4%   
Profit before tax Rs m3,142968 324.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m847-138 -612.3%   
Profit after tax Rs m2,2951,107 207.3%  
Gross profit margin %26.414.3 185.1%  
Effective tax rate %27.0-14.3 -188.7%   
Net profit margin %18.75.4 347.3%  
BALANCE SHEET DATA
Current assets Rs m11,71318,877 62.0%   
Current liabilities Rs m6,79111,896 57.1%   
Net working cap to sales %40.033.9 118.1%  
Current ratio x1.71.6 108.7%  
Inventory Days Days26378 336.4%  
Debtors Days Days343198 173.6%  
Net fixed assets Rs m10,61714,269 74.4%   
Share capital Rs m166341 48.7%   
"Free" reserves Rs m7,26515,798 46.0%   
Net worth Rs m7,43116,139 46.0%   
Long term debt Rs m04,706 0.0%   
Total assets Rs m22,33033,146 67.4%  
Interest coverage x409.11.6 26,314.3%   
Debt to equity ratio x00.3 0.0%  
Sales to assets ratio x0.60.6 88.6%   
Return on assets %10.38.6 119.8%  
Return on equity %30.96.9 450.3%  
Return on capital %42.413.0 325.4%  
Exports to sales %021.4 0.0%   
Imports to sales %13.115.2 85.8%   
Exports (fob) Rs mNA4,402 0.0%   
Imports (cif) Rs m1,6053,136 51.2%   
Fx inflow Rs m1,4654,402 33.3%   
Fx outflow Rs m1,6053,184 50.4%   
Net fx Rs m-1401,219 -11.5%   
CASH FLOW
From Operations Rs m2,3602,437 96.8%  
From Investments Rs m-215-6,265 3.4%  
From Financial Activity Rs m-9852,490 -39.5%  
Net Cashflow Rs m1,16024 4,739.8%  

Share Holding

Indian Promoters % 0.0 57.8 -  
Foreign collaborators % 51.8 0.0 -  
Indian inst/Mut Fund % 20.3 19.4 104.4%  
FIIs % 7.6 2.7 281.5%  
ADR/GDR % 0.0 0.0 -  
Free float % 48.2 42.3 114.0%  
Shareholders   56,730 16,430 345.3%  
Pledged promoter(s) holding % 0.0 85.7 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PROCTER & GAMBLE HEALTH With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on Procter & Gamble Health vs PLETHICO PHARMA

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Procter & Gamble Health vs PLETHICO PHARMA Share Price Performance

Period Procter & Gamble Health PLETHICO PHARMA S&P BSE HEALTHCARE
1-Day -0.55% -4.91% 1.18%
1-Month -7.47% -1.24% -0.75%
1-Year -3.02% -70.21% 61.82%
3-Year CAGR -9.12% -66.86% 18.16%
5-Year CAGR 5.75% -51.20% 19.79%

* Compound Annual Growth Rate

Here are more details on the Procter & Gamble Health share price and the PLETHICO PHARMA share price.

Moving on to shareholding structures...

The promoters of Procter & Gamble Health hold a 51.8% stake in the company. In case of PLETHICO PHARMA the stake stands at 57.8%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Procter & Gamble Health and the shareholding pattern of PLETHICO PHARMA.

Finally, a word on dividends...

In the most recent financial year, Procter & Gamble Health paid a dividend of Rs 95.0 per share. This amounted to a Dividend Payout ratio of 68.7%.

PLETHICO PHARMA paid Rs 0.0, and its dividend payout ratio stood at 0.0%.

You may visit here to review the dividend history of Procter & Gamble Health, and the dividend history of PLETHICO PHARMA.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.